semaglutide and alzheimer's Weight Loss Drug Shows Promise as Treatment : ScienceAlert Semaglutide in early-stage Alzheimer's Disease

The loss of dopaminergic signaling also leads to increased glutamatergic activity, which may contribute to neuronal excitability and worsen symptoms

It often complements other regenerative therapies by supporting the body's foundational repair mechanisms

Insurance and healthcare: A longer game Heres where things get really interesting for the long term

Watson WH, Greenwell JC, Zheng Y, Furmanek S, Torres-Gonzalez E, Ritzenthaler JD, et al

While the science behind collagen and glutathione is deep and nuanced, the application is simple: provide your body with high-quality building blocks and the protection it needs to keep them intact